chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hospitalization: 12/4/2022 - 12/7/2022 (3 days) Presentation to the ED: acute encephalopathy. COVID + date: 12/4/2022 Treatment: IV dexamethasone and Remdesivir  Discharge to: Home. 1. Moderna Lot # 030L20A 1/26/2021 2. Moderna Lot # 013M20A 2/23/2021 3. Moderna Lot # 066F21A 11/15/2021 4. Moderna Lot # 056M21A 4/24/2022 5. Moderna BiValent booster Lot # GH9702 11/7/2022
body hurting/body hurts/body aches; can hardly walk; weakness; swollen arm/; Swollen arm where the injection was given; This is a spontaneous report from a contactable consumer (patient herself). A 58-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: FA7485), via an unspecified route of administration, administered in left arm on 13Jul2021 (age at vaccination: 58 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included covid-19, ongoing diabetes mellitus, sinusitis, thyroiditis and pain. Concomitant medication(s) included topiramate (has been on for a couple of years) taken for headache; gabapentin (has been on for a few years); levothyroxine sodium (THYROXINE) (has been on for a couple of years) taken for thyroiditis; estradiol; montelukast sodium (SINGULAIR) 10mg taken for sinusitis; pravastatin; metformin 500mg taken for diabetes mellitus and hydrocodone taken for pain in her back and down her legs. On 13Jul2021, the patient's body was hurting/body hurts/body aches, can hardly walk, weakness, swollen arm where the injection was given which started yesterday evening and has gone down some since she soaked it. The patient stated that body pain started last night, or actually yesterday when she was at work; weakness started yesterday evening, it was about the same and has not gotten better. There was no treatment was given for the adverse events. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. There were no additional vaccines administered on same date of the Pfizer suspect. The adverse events did not require a visit to emergency room and physician's office. There were no other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The patient underwent lab tests and procedures which included sars-cov-2 test was positive on an unknown date. The outcome of the event pain, gait disturbance, asthenia, was not recovered; peripheral swelling, vaccination site pain was recovering. There was no product quality complaint (PQC) present.
very painful injection site with RED patch rash about 2" x 4" with defined border; tender and warm.
I have a weakness in my upper arms and shoulders, it's painful. I have loss of range of range of motion. At night the pain keeps me up I have trouble sleeping, I taking ibuprofen. It a deep aching pain and sharp pain and no strength I can hardly move. Lifting my arms over head hurts.
Developed rash - cluster of vesicles on right forearm (opposite arm of where vaccination administered), pruritis.  Denies fever, dyspnea or other symptoms.  Patient to follow-up at Urgent Care Center for Zoster culture of lesions to be obtained and sent.  Will follow with PCP.
I did two at home COVID test and they came out negative, I was treated with antibiotics. It was a lung infection. It took about 3-4 weeks to clear but I'm much better.
Vomiting and fever for 3 days.  Not seen in clinic, no treatment prescribed.
Pt received PPSV23 at 10:30AM during normal well visit. Feeling well. In the afternoon she reports she began to feel dizzy, arm (L) was heavy with red, swollen, tender spot at injection site. She denies fever. Used Ibuprofen, ice, BENADRYL-resolved next day.
I was exposed to COVID 12/18/21 by someone who was fully vaccinated, and their only symptom was a runny nose. On 12/19/21 and 12/20/21 I only experienced a sore throat. On 12/21/21 it felt like I had bronchitis with no nasal drip or discharge. On 12/22/21 felt like I had bad cold and sinus symptoms, I did not have a barking cough anymore just a mild wet cough. On 12/23/21 through 12/27/21 I had decreasing cold symptoms. I was nasal symptoms free from the 28th and 29th and on. I did start experiencing chest pains for about a month and half and since then it has gone away. As far as testing I tested negative on the 12/20/21 and 12/22/21 and tested positive on 12/23/21. I followed up with my doctor for chest pains and was ordered an Echocardiogram and Stress Test and my results looks normal and no concerns.
Vaccine DTAP injected 08/15.  Mother reports left arm swelling 08/15 - today left arm red swelling, warm.  Mother reports fever 08/15, 08/16 evening.  No fever today.
Information has been received from a nurse practitioner concerning a female who in approximately July 2009, was vaccinated with the third dose of GARDASIL (Lots # unknown). The nurse reported that one year after the last dose in approximately July 2010 of GARDASIL the patient developed "a severe case of genital warts". In approximately July 2010, the patient experienced severe case of genital warts after the last dose. The patient's severe case of genital warts after the last dose persisted. The patient sought medical attention. Additional information has been requested.
LOW GRADE FEVER; UNCONTROLLED CHILLS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN, expiry : UNKNOWN) dose was not reported, administered on 27-MAR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced uncontrolled chills. Treatment medications included: paracetamol. On 27-MAR-2021, the subject experienced low grade fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from low grade fever, and the outcome of uncontrolled chills was not reported. This report was non-serious.
Sick for 5 days with swollen, painful lymph nodes, fever, stiff neck.
Exhaustion for more than a week following the vaccine; This is a spontaneous report from a contactable consumer. This 59-year-old female consumer reported that: A 59-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 28Jan2021 10:00 (age at the time of vaccination was 59) as first dose, single for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient medical history and concomitant medications were not reported. Patient not diagnosed with covid-19 prior to vaccination. Patient was not received any other vaccine prior four weeks of vaccination and patient did not receive any medication prior two weeks of vaccination. Since vaccination patient not tested for covid-19. On unspecified date the patient experienced exhaustion for more than a week following the vaccine. Therapeutic measures were not taken as a result of the event. The outcome of the event was reported as recovering.  Information on the lot/batch number has been requested.  Follow-up (19Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
experienced "severe reactions; This case was reported by a pharmacist via call center representative and described the occurrence of adverse reaction in a male patient who received Herpes zoster (Shingrix) (batch number HY4GT, expiry date 21st September 2021) for prophylaxis.   On 21st June 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 9 months after receiving Shingrix, the patient experienced adverse reaction. The action taken with Shingrix was unknown. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. Several patients received the first dose of Shingrix and did not receive the second dose after a two to six months period. Pharmacist mentioned that 4 patients received the first dose in the pharmacy where she works but she only provided the details of one patient.  She did not provide his initials.  After call was transferred, the pharmacist told second line agent the reason patients delayed taking the second dose was because they experienced severe reactions which she described as having problems getting out of bed for three days. She stated she had already provided the information to the first line agent. No further details or information provided, other than what was documented. This case is one out of 4 cases reported by the same reporter.
12mo old baby received 2 Moderna Monovalent doses in the past and was given their first Moderna  Bivalent 0.25ml (blue cap) instead of Moderna Bivalent 0.2ml (dark pink cap). Medical Assistant had patient wait 15 minutes after vaccines, no reactions reported.
The night of vaccination, pt began to experience nausea, loss of appetite, body aches, hot and cold sweats, headache, swollen lymph nodes, dizziness, and fatigue.  These symptoms have continued up to the present, three days later.  During the night of 2/10/21, she woke up in a state of delirium with disorientation to person, place, and time. This resolved within hours and she has not had any other episodes of altered mental status.
Family member concern of immunization causing lack of experience language between and 18-24 months; Request filled out an request of grandmother
Gradually over time after 2nd dose I am experiencing severe waves of vertigo, nausea and brain fog.
After receiving the Pfizer Co Vid vaccine 5pm about 2 hrs later on the same day I begin to light headed when getting up and down sitting or standing and when walking dizziness later one around 11pm severe arm pain like getting hit in the arm and severe abdomen pain it is now 1am and the pain is still very light facial puffiness also more like fluid then allergic reaction no fever or anything else yet but it's still day 1 and I have heard that can start a few days later. This was my 1st dose with Pfizer
Pt. felt nauseated about 4 minutes after her vaccination and ran out to the bathroom where staff followed and witnessed emesis. The pt. also felt weak and was unsteady on her feet, her  brother and staff accompanied her back to the observation area where she appeared flushed and tremulous, with ongoing nausea but no further vomiting, could not answer questions.
Dizziness that lead to fainting 9-10 mins after the vaccine. Gained consciousness  a few seconds later.  Stayed at the pharmacy for about an hour for further observation.
This spontaneous report as received from a registered nurse refers to a currently 59 year old female patient. The patient had a history of phlebitis of left upper leg. Her concurrent conditions included Lyme Disease. She was also allergic to unspecified sulfa drugs, lactose, shellfish, feathers, grasses, trees and dust mites. On 19-NOV-2015, the patient was vaccinated with a first dose of RECOMBIVAX HB injection, 1 ml, intramuscularly, lot # K020218, expiry date 24-OCT-2016 (site of administration was not reported). Concomitant therapies included aspirin (manufacturer unknown) and unspecified vitamins. On 05-JAN-2016, the patient received the second dose of RECOMBIVAX HB injection, 1 ml, intramuscularly, lot/batch # reported as L013051, expiry date 15-APR-2017 (site of administration was not reported). On an unknown date, the patient experienced diverticulitis and viral bronchitis and was hospitalized due to the events on an unknown date. She was treated with unspecified antibiotics at an unspecified hospital. The outcome of the events was not reported. The nurse stated that, on an unknown date, the patient was seen by an unspecified healthcare provider and was cleared to receive third dose of RECOMBIVAX HB. The relatedness between the events and RECOMBIVAX HB was not provided. Upon internal review, the event of diverticulitis was considered to be medically significant. Additional information is not expected, as there was no consent given to contact the reporter.
Brief periods of shortness of breath, each lasting 2 to 5 minutes.  Also had small sharp pain in right calf, lasting 10 minutes.   Wasn't severe, so no Dr called.
Blood pressure 210/120; A spontaneous report was received from a consumer concerning a 79-year-old, female patient who received Moderna's COVID-19 Vaccine, and who experienced a hypertensive crisis.    The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 14-Jan-2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (LOT unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 14-Jan-2021 A patient received the Moderna vaccine. On 15-Jan-2021, the patient experienced a blood pressure of 210/120.  The friend reported that the patient's baseline blood pressure is 124/74.  Patient's reported heart rate was 75 and her oxygen saturation was 100%.  Patient visited the emergency room on 15-Jan-2021.  No additional details were provided.   Treatment information was not provided.   Action taken with mRNA-1273 in response to the event, a hypertensive crisis, was not provided.   The outcome of the event, a hypertensive crisis, was not reported.; Reporter's Comments: This case concerns a female patient, who experienced a serious unexpected event of hypertensive crisis. The event of hypertensive crisis occurred 2 days after mRNA-1273 (lot # unknown) administration. Treatment details were not provided. Very limited information regarding the events have been provided at this time.  Based on temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient is a 82 y.o. female patient of MD with history of breast cancer s/p left mastectomy and right lumpectomy, atrial fibrillation, chronic anticoagulation with Eliquis, DM2, HTN presented with shortness of breath with recent COVID 19 positive test results   Acute COVID-19 Virus Infection Possible secondary bacterial pneumonia  Acute hypoxic respiratory failure  Date of onset of symptoms: 12/18/2022 Symptoms present on admission: Shortness of breath, hypoxemia Date of covid positive test: 12/19/2022; repeat for hospitalization on 1/2/2023 Vaccination status: vaccinated ? Imaging: CT pulmonary arteries - no PE; but shows Multifocal pneumonia with reactive lymph nodes in mediastinum and hilum.  ? Influenza negative  ? Blood culture no growth to date  ? Sputum culture no growth to date  ? Pro calcitonin low ? Urine Strep pneumonia Ag negative   Oxygen requirements on admission:6L Oxygen saturation 95% on 2 L nasal cannula Medical therapy:  ? Completed course of Decadron treatment ? Stopped Levaquin 1/5 as no clear bacterial infection  ? Mucinex ? IV lasix for dry lung strategy ? Per Pulm not a candidate for Toci or other immunosuppressant  The patient is clinically improved, isolation can be discontinued. Continue Mucinex, Lasix, oxygen support.          OSA Continue to monitor and treat as needed.   Paroxysmal atrial fibrillation Chronic HFpEF Aortic valve stenosis Hypertension, essential Follows with cardiology Previous cardioversion June 2022 12/12/2021 echo with normal EF Continue Lasix, flecainide, verapamil, and Eliquis.           DM2 July 2022 A1c 6.8 Continue Lantus insulin Continue to monitor the blood sugars and treat as needed with sliding scale coverage.
Caller stated a family member had the first dose of Pfizer's COVID vaccine and got COVID.; Caller stated a family member had the first dose of Pfizer's COVID vaccine and got COVID.; This is a spontaneous report from a contactable nurse. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, it was reported that the patient had the first dose of Pfizer's COVID vaccine and got COVID. The patient underwent lab tests and procedures which included sars-cov-2 test: got covid on an unspecified date. The outcome of the events was unknown.   Information about batch/lot number has been requested.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 vaccine can not be excluded for the reported events of COVID-19 test positive and drug ineffective due to temporal relationship.  Case will be re-assessed upon the additional information provided.
A employee that was in charge of covid vaccine here never entered covid vaccine's into database. When I went to enter all vaccine's in I noticed this lot number states it expired 5/2022 but the card that comes in the package of vaccine states used by date is September. When I contacted Hospital pharmacy I was told that the expiration date is extended 12 months from manufacture date. I was also informed there is a website to check expiration dates. I put the lot number in it states 8/31/2022. Management at hospital pharmacy contacted pfizer and they confirmed that this vaccine is expired.
mom called paramedics because pt had fever of 104;paramedics state temp 100.3 p/APAP given by mouth;febrile rxn to DTP;mom reported this @ next clinic visit;t100.6 R, pulse 124, resp 24;pt w/hemanioma noted to lt cheek;pt irritable;
Within 5 mins of the shot, I got dizzy but I sat down and that feeling went over. After dinner the same day, I had vertigo and had to vomit. Since then there has been nausea and headache, and I have trouble sleeping in. I feel some more discomfort after eating food.  I have intermittent fever also. It has been about 10 days today since I got my COVID Pfizer shot  and I still don't feel physically well. I just wanted to report this, as the impression from documentation I read is that symptoms should go away in 3-4 days.
Right sided tingling and heaviness. Started with pins and needles in right great toe and spread as tingling and heaviness up right leg to right arm and right side of face
lot 9266 exp 05/31/21   shot administered 15:24 and reactions occurred 15:35.  Severe sweating, dizziness, lightheadedness, fast HR.  Taken to ED by wheelchair by RN.
very sleepy and tired; no appetite; cant get up; felt in general body ache/had stronger pain did not go to work; had a major cold; fever; chills; 2nd day was really bad; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (very sleepy and tired), DECREASED APPETITE (no appetite), DYSSTASIA (cant get up), PAIN (felt in general body ache/had stronger pain did not go to work) and NASOPHARYNGITIS (had a major cold) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced SOMNOLENCE (very sleepy and tired), DECREASED APPETITE (no appetite), DYSSTASIA (cant get up), PAIN (felt in general body ache/had stronger pain did not go to work), NASOPHARYNGITIS (had a major cold), PYREXIA (fever), CHILLS (chills) and FATIGUE (2nd day was really bad). On 03-Apr-2021, SOMNOLENCE (very sleepy and tired), DECREASED APPETITE (no appetite), DYSSTASIA (cant get up), PAIN (felt in general body ache/had stronger pain did not go to work), NASOPHARYNGITIS (had a major cold), PYREXIA (fever), CHILLS (chills) and FATIGUE (2nd day was really bad) had resolved.            No treatment information was provided.  No concomitant medication was provided.    This case was linked to MOD-2021-133160 (Patient Link).
Immune system -- mouth canker sores, previously controlled, began to flare up.  A couple smaller ones recently subsided.  The canker sores (under my tongue) remain incessant (painful) for well over a month.
MODERATE TO SEVERE PAIN ON INJECTION SITE WITH REDNESS AND MODERATE SWELLING. PAIN INCREASED WITH ELEVATION OF EXTREMITY. COUGH STARTED ON 12/22/2020. MILD DYSPEPSIA.
Client received second dose of COVID19 vaccine at 2:28pm. While sitting in observation room with her mom, she became dizzy, light headed and nauseous. Nursing staff evaluated client. She stated she had only had a muffin for breakfast. Staff provided juice, water and nutri-grain bar. Due to nausea, only able to drink a small amount of juice. Moved client to cot. EMS was called. Provided cold compress for forehead. She continued to drink the juice. Pulse ox was taken and was 98 continuously while she was on the cot. Nursing staff evaluated her for symptoms and improvement. She state she was still dizzy, lightheaded, and nauseous. She also stated her throat hurt/felt tight. EMS arrived. Interpreter used during event.
HAD VACCINATION ON NOV. 27.  TWO DAYS LATER IT WAS HURTING, RED, SWOLLEN AND HARD.  TODAY, NOV. 29 IT IS WORSE.  THE PAIN, SWELLING, HARDNESS ETC. ARE GETTING WORSE.  I HAVE PUT ICE ON IT AND TAKEN ADVIL WITH NO RELIEF.  I MAY HAVE TO SEE THE DOCTOR ABOUT IT.  I AM NOT SURE OF THE EXACT NAME OF THE SHOT.
Upon injection I could feel burning of the liquid, it felt like worms, or bubbling. The next day, 02/04/2021, around the injection I had a hot, red, circle and that grew with time. I waited around a week before I went to see the doctor. I was losing the feeling in my hand, my fingers were becoming numb, I was not able to lift anything with my fingers, my arm was very sore and there was a lot of shooting pain in my arm. On 02/11/2021, I went in to see the doctor. He diagnosed it with an infection at the injection site. He treated it with a z-pack and a nerve relaxer, Gabapentin. It took 2 weeks before it subsided.
2 of the patients who got the vaccine were 16 and 17; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (2 of the patients who got the vaccine were 16 and 17) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (2 of the patients who got the vaccine were 16 and 17). On 29-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (2 of the patients who got the vaccine were 16 and 17) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  So far, no adverse reactions was reported by either of the patients.   This case was linked to MOD-2021-272172.